GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS) » Definitions » Revenue

ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS) Revenue : ₺77.09 Mil (TTM As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is ICU Girisim Sermayesi Yatirim Ortakligi AS Revenue?

ICU Girisim Sermayesi Yatirim Ortakligi AS's revenue for the three months ended in Jun. 2024 was ₺63.88 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2024 was ₺77.09 Mil. ICU Girisim Sermayesi Yatirim Ortakligi AS's Revenue per Share for the three months ended in Jun. 2024 was ₺0.92. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was ₺1.24.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, ICU Girisim Sermayesi Yatirim Ortakligi AS's highest 3-Year average Revenue per Share Growth Rate was 903.00% per year. The lowest was -88.70% per year. And the median was -50.50% per year.


ICU Girisim Sermayesi Yatirim Ortakligi AS Revenue Historical Data

The historical data trend for ICU Girisim Sermayesi Yatirim Ortakligi AS's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ICU Girisim Sermayesi Yatirim Ortakligi AS Revenue Chart

ICU Girisim Sermayesi Yatirim Ortakligi AS Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.64 - - -

ICU Girisim Sermayesi Yatirim Ortakligi AS Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 13.22 - 63.88

Competitive Comparison of ICU Girisim Sermayesi Yatirim Ortakligi AS's Revenue

For the Asset Management subindustry, ICU Girisim Sermayesi Yatirim Ortakligi AS's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ICU Girisim Sermayesi Yatirim Ortakligi AS's Revenue Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, ICU Girisim Sermayesi Yatirim Ortakligi AS's Revenue distribution charts can be found below:

* The bar in red indicates where ICU Girisim Sermayesi Yatirim Ortakligi AS's Revenue falls into.



ICU Girisim Sermayesi Yatirim Ortakligi AS Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺77.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ICU Girisim Sermayesi Yatirim Ortakligi AS  (IST:ICUGS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


ICU Girisim Sermayesi Yatirim Ortakligi AS Revenue Related Terms

Thank you for viewing the detailed overview of ICU Girisim Sermayesi Yatirim Ortakligi AS's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


ICU Girisim Sermayesi Yatirim Ortakligi AS Business Description

Traded in Other Exchanges
N/A
Address
Sair Esref Boulevard Ragip Samli Business Center, Block No. 6 Ic Kapi No. 706, Ismet Kaptan District, Izmir, Konak, TUR, 34398
ICU Girisim Sermayesi Yatirim Ortakligi AS is a Turkey based investment banking company. It operates as a venture capital company. The company invests in portfolio of companies which includes OEP RHEA Turkey Tech, Seta Medical, Netsafe Information System, and RML Lines.

ICU Girisim Sermayesi Yatirim Ortakligi AS Headlines

No Headlines